Article Details

Wilson Sonsini Advises ReCode Therapeutics in Oversubscribed Series B Financing

Retrieved on: 2022-06-29 17:22:12

Tags for this article:

Click the tags to see associated articles and topics

Wilson Sonsini Advises ReCode Therapeutics in Oversubscribed Series B Financing. View article details on HISWAI: https://www.wsgr.com/en/insights/wilson-sonsini-advises-recode-therapeutics-in-oversubscribed-series-b-financing.html

Excerpt

On June 29, 2022, ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of messenger RNA (mRNA) and gene ...

Article found on: www.wsgr.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up